Gene-editing therapy shows powerful one-dose reduction in harmful cholesterol
Independent - 10-Nov-2025CRISPR therapy cut LDL and triglycerides by roughly 50% after a single infusion
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Cardiologist and researcher based at the Cleveland Clinic
Dr Steven Nissen is a highly distinguished cardiologist and researcher based at the Cleveland Clinic, where he serves as Chief Academic Officer of the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute and holds the Lewis and Patricia Dickey Chair in Cardiovascular Medicine. With over 35 years of clinical and research experience, he is world-renowned for pioneering work in intravascular ultrasound (IVUS) imaging to track the progression and regression of coronary artery disease, and for spearheading large multicentre trials in atherosclerosis. He has authored more than 400 journal articles and 60 book chapters, and has been a powerful voice in drug-safety advocacy, having testified before the U.S. Congress on the need for reform in regulatory oversight. Beyond his professional activities, Dr Nissen is known for bicycling, amateur photography, and a firm commitment to patient care and scientific integrity.
Visit website: https://providers.clevelandclinic.org/provider/steven-nissen/4268279
See alsoDetails last updated 10-Nov-2025
CRISPR therapy cut LDL and triglycerides by roughly 50% after a single infusion